Omnic (Tamsulosin Hydrochloride)

Tamsulosin Hydrochloride is used in urological conditions that involve smooth‑muscle tone in the prostate and bladder neck.

• Benign prostatic hyperplasia (BPH): relieves urinary obstruction and improves urine flow.
• Chronic prostatitis: may reduce urinary symptoms associated with prostatitis.
• Pre‑surgical preparation for transurethral resection of the prostate (TUR‑P): helps reduce intra‑operative bleeding by relaxing prostatic smooth muscle.

• Tamsulosin selectively blocks alpha‑1A adrenergic receptors located in the prostate, bladder neck, and urethra. By inhibiting these receptors, it reduces smooth‑muscle contraction, leading to relaxation of the urinary outflow tract and decreased resistance to urine flow, which alleviates symptoms of urinary obstruction.

Tamsulosin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Dizziness or light‑headedness, especially on standing.
• Abnormal ejaculation, such as reduced volume or retrograde flow.
• Nasal congestion or runny nose.
• Headache.
• Fatigue.

Serious or Rare Side Effects

• Severe hypotension or syncope.
• Priapism (prolonged erection).
• Allergic reactions including rash, itching, or swelling.
• Angio‑edema affecting face or throat.
• Acute urinary retention.

Patients should be counseled on safety considerations before starting tamsulosin therapy.

• Orthostatic hypotension: rise slowly from sitting or lying positions.
• Cardiovascular disease: monitor blood pressure and heart rate.
• Liver impairment: use with caution; dose adjustment may be needed.
• Drug interactions: review concomitant medications for potential additive hypotensive effects.
• Surgery: inform surgeons of tamsulosin use prior to procedures involving spinal or epidural anesthesia.
• Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Tamsuloset may interact with several drug classes, requiring clinical awareness.

Major Interactions (Avoid)

• Phosphodiesterase‑5 inhibitors (e.g., sildenafil): increased risk of profound hypotension.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise plasma tamsulosin levels.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents (e.g., ACE inhibitors, diuretics): additive blood‑pressure‑lowering effect.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): may enhance orthostatic hypotension.
• Beta‑blockers: combined effect on heart rate and blood pressure.